PNB-56645-33342
2 vaccinations
1 coded response
20 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 064 / CT
- Registered
- 2022-07-23
- Relationship
- Child or adolescent in my care
- Guardian
- CBD-32746-17970
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-23
Registered in v-safe
-
2022-07-23
Dose 1 — Pfizer-BioNTech
- 2022-07-23
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-07-27
- 2022-07-28
- 2022-07-29
- 2022-07-30
- 2022-08-06
-
2022-08-15
Survey response — day 21, dose 1, dependentMedDRA: Exposure to SARS-CoV-2, Pyrexia — Feeling: GoodFree text: Slight fever. Rest of family tested positive for covid. He did not test.MedDRA releases: 2024-11 · check-in free text available
- 2022-08-20
- 2022-08-27
- 2022-09-05
-
2022-10-29
Dose 2 — Pfizer-BioNTech
- 2022-11-06
- 2022-11-14
- 2022-11-19
- 2022-11-26
- 2022-12-05
- 2023-01-30
- 2023-04-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-23 | Pfizer-BioNTech | No |
| 2 | 2022-10-29 | Pfizer-BioNTech | No |
Free text
Release 12 — day 21, dose 1, dependent
Symptoms: Slight fever. Rest of family tested positive for covid. He did not test.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release